Workflow
体外诊断仪器及配套试剂
icon
Search documents
亚辉龙8月26日获融资买入2931.41万元,融资余额4.55亿元
Xin Lang Cai Jing· 2025-08-27 02:13
Core Viewpoint - The company, Aihuilong, experienced a decline in stock price and trading volume, with significant financing activities indicating high leverage levels in the market [1][2]. Group 1: Financial Performance - For the first half of 2025, Aihuilong reported revenue of 808 million yuan, a year-on-year decrease of 15.79% [2]. - The net profit attributable to shareholders was 26.27 million yuan, reflecting a substantial year-on-year decline of 84.82% [2]. Group 2: Shareholder and Market Activity - As of August 26, Aihuilong's financing balance was 455 million yuan, accounting for 5.01% of its market capitalization, indicating a high level of leverage compared to the past year [1]. - The company had a total of 11,900 shareholders as of June 30, with a decrease of 4.07% from the previous period [2]. - The average number of circulating shares per shareholder increased by 4.27% to 47,894 shares [2]. Group 3: Dividend and Institutional Holdings - Aihuilong has distributed a total of 693 million yuan in dividends since its A-share listing, with 531 million yuan distributed over the past three years [3]. - As of June 30, 2025, Huabao Zhongzheng Medical ETF was the sixth largest circulating shareholder, holding 11.42 million shares, an increase of 171,400 shares from the previous period [3].